Imperial College London

ProfessorJaneApperley

Faculty of MedicineDepartment of Immunology and Inflammation

Chair of the Department of Haematology
 
 
 
//

Contact

 

+44 (0)20 3313 3237j.apperley

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4N3CHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Journals

Innes A, Wooley P, Szydlo R, et al., Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality., Leukemia, ISSN:1476-5551

Clark RE, Polydoros F, Apperley JF, et al., 2019, De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial, Lancet Haematology, Vol:6, ISSN:2352-3026, Pages:e375-e383

Nesr G, Claudiani S, Khorashad J, et al., 2019, The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients, Leukemia & Lymphoma, ISSN:1042-8194

Branford S, Kim DDH, Apperley JF, et al., 2019, Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia., Leukemia, ISSN:0887-6924

Xu D, Claudiani S, Naresh K, et al., 2019, Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1., Leuk Lymphoma, Pages:1-2

More Publications